News
Ensysce Biosciences (ENSC) has entered into definitive agreements, providing the Company with an aggregate gross proceeds of approximately $1.1 ...
SAN DIEGO, CA / ACCESS Newswire / March 31, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback